eBioscience Purchase Nudges Affymetrix Q2 Revenues up 3 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Affymetrix said after the close of the market on Tuesday that second-quarter revenues increased 3 percent year over year, helped along by a $1.4 million contribution from its eBioscience acquisition.

For the three months ended June 30, revenues for the Santa Clara, Calif.-based microarray firm increased to $66.4 million, up from $64.7 million in the year-ago period. The results beat the average analyst estimate of $65.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.